Aryl-isoxazolo-4-yl-oxadiazole derivatives
US7541372B2 · kind B2 · utility
7Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2006 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Jan 28, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is concerned with isoxazol-4-yl-oxadiazole derivatives of formulawherein This class of compounds has high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.